Does chirality matter?: Pharmacodynamics of enantiomers of Methylphenidate in patients with attention-deficit/hyperactivity disorder

Journal of Clinical Psychopharmacology

Volumn 28, Issue 3 SUPPL. 2, 2008, Pages

  Quinn, Declan ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; DOPAMINE; METHYLPHENIDATE;

ANIMAL; ATTENTION DEFICIT DISORDER; BLOOD; BRAIN; CORPUS STRIATUM; DELAYED RELEASE FORMULATION; DRUG EFFECT; HUMAN; METABOLISM; PAPIO; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTISCANNING; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DELAYED-ACTION PREPARATIONS; DOPAMINE; HUMANS; METHYLPHENIDATE; PAPIO; POSITRON-EMISSION TOMOGRAPHY; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 52049085094     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181744aa6     Document Type: Article

References (23)

1. Volkow ND, Wang GJ, Fowler JS, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry. 1998;155:1325-1331. (Pubitemid 28471187)
2. Volkow ND, Wang G, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci. 2001;21:RC121.
3. Volkow ND, Wang GJ, Fowler JS, et al. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse. 2002;43:181-187. (Pubitemid 34087672)
4. Volkow ND, Fowler JS, Wang G, et al. Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord. 2002;6(suppl 1):S31-S43.
5. Volkow ND, Fowler JS, Wang GJ, et al. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur Neuropsychopharmacol. 2002;12:557-566. (Pubitemid 35414373)
6. Volkow ND, Wang GJ, Fowler JS, et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry. 2004;161:1173-1180. (Pubitemid 38859165)
7. Volkow ND, Wang GJ, Fowler JS, et al. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1410-1415. Epub Jan 12. (Pubitemid 40798562)
8. Croom KF, Goa KL. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Drugs. 2003;63:2769-2802. (Pubitemid 38049994)
9. Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis. 1999;28:352-364. (Pubitemid 29241226)
10. Mehvar R, Brocks DR, Vakily M. Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs. Clin Pharmacokinet. 2002;41:533-558. (Pubitemid 34848362)
11. Agranat I, Caner H, Caldwell J. Putting chirality to work: the strategy of chiral switches. Nat Rev Drug Discov. 2002;1:753-768. (Pubitemid 37361560)
12. Ding YS, Fowler JS, Volkow ND, et al. Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and l-threo-methylphenidate in the human and baboon brain. Psychopharmacology. 1997;131:71-78. (Pubitemid 27242857)
13. Ding YS, Fowler JS, Volkow ND, et al. Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain. J Nucl Med. 1995;36:2298-2305.
14. Teo SK, Stirling DI, Thomas SD, et al. Neurobehavioral effects of racemic threo-methylphenidate and its D and L enantiomers in rats. Pharmacol Biochem Behav. 2003;74:747-754. (Pubitemid 36126553)
15. Davids E, Zhang K, Tarazi FI, et al. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning. Psychopharmacology (Berl). 2002;160:92-98. (Pubitemid 34169830)
16. Wigal S, Swanson JM, Feifel D, et al. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d, l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004;43:1406-1414. (Pubitemid 39411041)
17. Arnold LE, Lindsay RL, Conners CK, et al. A double-blind, placebocontrolled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2004;14:542-554.
18. Quinn D, Wigal S, Swanson J, et al. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d, lthreomethylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004;43:1422-1429. (Pubitemid 39411043)
19. Silva R, Tilker HA, Cecil JT, et al. Open-label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2004;14:555-563.
20. Greenhill LL, Muniz R, Ball RR, et al. Efficacy and safety of dexmethylphenidate extended-release capsules in children with attentiondeficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45:817-823. (Pubitemid 43932908)
21. Silva RR, Muniz R, Pestreich L, et al. Dexmethylphenidate extendedrelease capsules: In children with attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. In press.
22. Silva RR, Muniz R, Pestreich L, et al. Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006;16:239-251. (Pubitemid 43902421)
23. Spencer TJ, Adler LA, McGough JJ, et al, and the Adult ADHD Research Group. Efficacy and safety of dexmethylphenidate extendedrelease capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61:1380-1387. Epub 2006 Nov. 29 [Epub ahead of print]. (Pubitemid 46855767)